Artemis Medicare Services Ltd. has formed a highly bullish technical setup on the weekly timeframe.
The stock recently broke out above a critical horizontal resistance line at the 343.50 level.
This breakout is validated by a massive, anomalous spike in trading volume, indicating strong institutional accumulation and high conviction behind the move.
Following a prolonged period of volatility and basing, this price action suggests a structural shift in momentum.
The previous heavy resistance at 343.50 should now serve as a strong support floor for future price action.
Entry Point: Consider entering near the current market price of 357.70, or scale in on a potential retest of the 343.50 breakout level.
Target: Based on a measured move of the prior consolidation depth (approximately 200.00 to 343.00), a realistic medium-term target sits in the 450.00 - 480.00 zone.
Stop Loss: A strict stop loss should be placed at a weekly close below 315.00.
Falling below this level would mean breaking back below the breakout candle's momentum base, invalidating the current bullish thesis.
The stock recently broke out above a critical horizontal resistance line at the 343.50 level.
This breakout is validated by a massive, anomalous spike in trading volume, indicating strong institutional accumulation and high conviction behind the move.
Following a prolonged period of volatility and basing, this price action suggests a structural shift in momentum.
The previous heavy resistance at 343.50 should now serve as a strong support floor for future price action.
Entry Point: Consider entering near the current market price of 357.70, or scale in on a potential retest of the 343.50 breakout level.
Target: Based on a measured move of the prior consolidation depth (approximately 200.00 to 343.00), a realistic medium-term target sits in the 450.00 - 480.00 zone.
Stop Loss: A strict stop loss should be placed at a weekly close below 315.00.
Falling below this level would mean breaking back below the breakout candle's momentum base, invalidating the current bullish thesis.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。